Dr. Baird is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 E Duarte Road
Duarte, CA 91010Phone+1 626-218-2405Fax+1 626-389-3058- Is this information wrong?
Summary
- I am an assistant professor in the Division of Lymphoma, Department of Hematology and HCT at City of Hope National Medical Center in Duarte, CA. I am boarded in Internal Medicine, Hematology, and Medical Oncology. I have a background in clinical and translational research, and specialize in CAR-T therapies for hematologic malignancies. My particular research interests lie in novel drug development and translational pathobiology for leukemia and lymphoma.
Clinical Expertise
- Hematologic oncology, Myeloproliferative disease, Anemia
Education & Training
Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2020 - 2021- Stanford Health CareCancer Cellular Therapies, 2019 - 2020
- Stanford Health CareFellowship, Hematology and Medical Oncology, 2016 - 2019
University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2016- University of Pennsylvania Health SystemInternship, Internal Medicine, 2013 - 2014
University of Arkansas For Medical Sciences College of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2016 - 2026
PA State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Richard V. Ebert Award Dept. of Internal Medicine, UAMS, 2013
- Graduated with Honors in Research UAMS College of Medicine, 2013
- Clinical Research Training Program (CRTP) Fellow OCRTME, National Institutes of Health (NIH), 2012
Clinical Trials
- Natural History of Sickle Cell Disease Start of enrollment: 2004 Apr 29
- Carbon Monoxide Levels and Sickle Cell Disease Severity Start of enrollment: 2012 Jan 26
- CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies Start of enrollment: 2017 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma.Esther H Nie, Yi-Jiun Su, John H Baird, Neha Agarwal, Sushma Bharadwaj, Wen-Kai Weng, Melody Smith, Saurabh Dahiya, May H Han, Jeffrey E Dunn, Lucas B Kipp, David B Mi...> ;Blood Advances. 2024 Mar 26
- A Primer on Chimeric Antigen Receptor T-cell Therapy-related Toxicities for the Intensivist.Shin Yeu Ong, John H Baird> ;Journal of Intensive Care Medicine. 2023 Oct 29
- 5 citationsBendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-c...Shin Yeu Ong, Stacy Pak, Matthew Mei, Yan Wang, Leslie Popplewell, John H Baird, Alex F Herrera, Geoffrey Shouse, Liana Nikolaenko, Jasmine Zain, James Godfrey, Myo Ht...> ;American Journal of Hematology. 2023 Nov 1
- Join now to see all
Books/Book Chapters
Press Mentions
Scotland's Most Promising Scientists Awarded £12 MillionOctober 15th, 2020
Our Great Talent for Invention Will Lead Us Out of Darkness, Says LEO McKINSTRYApril 4th, 2020
Committees
- Ad Hoc Reviewer, British Journal of Haematology Editorial Board 2015 - Present
- Curriculum Author, Hospital of the Univ. of Pennsylvania Dept. of Medicine Nightfloat Curriculum Committee 2014 - 2016
Professional Memberships
- Member
- Member
- Member
- Member
Hospital Affiliations
City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
